Health Canada and Biosimilar Drugs – Important Information for Healthcare Professionals

The following notice was received by the ORA from Health Canada on December 3, 2018: Health Canada’s Biologics and Genetic Therapies Directorate is asking healthcare professionals who prescribe, dispense or administer biologic drugs […]

Read More…


Opportunity for Arthritis Health Professionals!

Do you know ou know or work with health professionals who want to stay current withevidence-based knowledge in the field of rheumatology and arthritis care? Please share this important information: AHPA Opportunities […]

Read More…


A New Quality Standard is Now Available for Osteoarthritis

For further information, please visit this link: New Quality Standard – Osteoarthritis […]

Read More…


Concerned About the CPSO Draft Policy Titled “Continuity of Care?”

The following link will take you to the members’ only section of our website. Here you will find instructions on how to share your concerns about the CPSO draft policy. You will be […]

Read More…


New Infliximab Biosimilar (Renflexis) Approved by ODB With LU code Criteria

To review the update from the MOHLTC, please visit this link: Renflexis FAQs. The updated ORA EAP Forms are available via this link: ORA EAP Forms. […]

Read More…


OHIP+ Changes

With the recent change in provincial government leadership, many of you may be wondering how the OHIP+ Program will be affected. The ORA Executive has reached out to our key contacts at the […]

Read More…


Updated: ORA Position – Biosimilar Non-Medical Switching

The ORA Board of Directors is pleased to publish an official position statement on non-medical switching. Recently, we amended the document to include Frequently Asked Questions. To review this important document, please visit […]

Read More…


Announcing Call for 2018 Arthritis Alliance of Canada Research Awards Applications

The Arthritis Alliance of Canada (AAC) is pleased to launch the 3rd round of the Research Awards Program and announce the 2018 “Call for Applications”. The program was intended to nationally recognise high […]

Read More…


Sad news on the passing of Dr. Sydney Gershon

We are sad to share the news that Dr. Sydney Gershon passed away on April 30, 2018 at Sunnybrook Hospital in Toronto. Dr. Gershon was a member of the Ontario Rheumatology Association, a […]

Read More…


OMA & ORA Updates from Dr. Baer & Dr. Averns – Video Link

Please find below a link to access the archived video of the 2018 OMA update presented by Dr. Philip Baer, and the 2018 ORA update presented by Dr. Henry Averns on April 12, […]

Read More…